The global demand for Venlafaxine, a serotonin-norepinephrine reuptake inhibitor (SNRI) used to treat major depressive disorder, generalized anxiety disorder, and panic disorder, continues to expand as mental health awareness grows worldwide. For pharmaceutical exporters, API manufacturers, and distributors, understanding the landscape of Venlafaxine buyers is essential for building sustainable business relationships. This guide explores the key markets, regulatory considerations, and practical strategies for connecting with legitimate Venlafaxine buyers globally. Understanding the Venlafaxine Global Market The Venlafaxine market has demonstrated steady growth, driven by the rising prevalence of mental health disorders and the widespread availability of generic formulations. The market was valued at approximately USD 3.47 billion and is projected to…